AU2001239275A1 - Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives - Google Patents

Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives

Info

Publication number
AU2001239275A1
AU2001239275A1 AU2001239275A AU3927501A AU2001239275A1 AU 2001239275 A1 AU2001239275 A1 AU 2001239275A1 AU 2001239275 A AU2001239275 A AU 2001239275A AU 3927501 A AU3927501 A AU 3927501A AU 2001239275 A1 AU2001239275 A1 AU 2001239275A1
Authority
AU
Australia
Prior art keywords
protein transferase
transferase inhibitor
farnesyl protein
podophyllotoxin derivatives
inhibitor combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001239275A
Inventor
Mary Ellen Margaret Rybak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of AU2001239275A1 publication Critical patent/AU2001239275A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU2001239275A 2000-02-29 2001-02-26 Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives Abandoned AU2001239275A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00200695 2000-02-29
EP00200695 2000-02-29
PCT/EP2001/002167 WO2001064198A2 (en) 2000-02-29 2001-02-26 Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives

Publications (1)

Publication Number Publication Date
AU2001239275A1 true AU2001239275A1 (en) 2001-09-12

Family

ID=8171114

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001239275A Abandoned AU2001239275A1 (en) 2000-02-29 2001-02-26 Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives

Country Status (5)

Country Link
EP (1) EP1267871A2 (en)
JP (1) JP2003525238A (en)
AU (1) AU2001239275A1 (en)
CA (1) CA2397256A1 (en)
WO (1) WO2001064198A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2581125C (en) 2004-09-22 2013-04-23 Nippon Kayaku Kabushiki Kaisha Modified poly(ethylene oxide-amino acid) copolymer, micelle preparation, and anticancer agent containing the same
US20070213366A1 (en) 2005-12-23 2007-09-13 Justman Craig J Treatment of Synucleinopathies
US8323669B2 (en) 2006-03-28 2012-12-04 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of taxane
AU2007252678A1 (en) * 2006-05-18 2007-11-29 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of podophyllotoxin
JP5503872B2 (en) 2006-11-06 2014-05-28 日本化薬株式会社 Polymer derivatives of nucleic acid antimetabolites
WO2008056654A1 (en) 2006-11-08 2008-05-15 Nippon Kayaku Kabushiki Kaisha Polymeric derivative of nucleic acid metabolic antagonist
CN101808651B (en) 2007-09-28 2013-03-27 日本化药株式会社 Polymer conjugate of steroid
US8920788B2 (en) 2008-03-18 2014-12-30 Nippon Kayaku Kabushiki Kaisha High-molecular weight conjugate of physiologically active substances
JP5366940B2 (en) 2008-05-08 2013-12-11 日本化薬株式会社 Polymer conjugate of folic acid or folic acid derivative
US8808749B2 (en) 2009-05-15 2014-08-19 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of bioactive substance having hydroxy group
KR20140024833A (en) 2010-11-17 2014-03-03 니폰 가야꾸 가부시끼가이샤 Novel polymer derivative of cytidine metabolism antagonist
CA2847114C (en) 2011-09-11 2018-08-21 Nippon Kayaku Kabushiki Kaisha Method for manufacturing block copolymer
ES2628365T3 (en) 2012-10-16 2017-08-02 Janssen Pharmaceutica N.V. Phenyl-linked quinolinyl modulators of ROR-GAMA-T
LT2909192T (en) 2012-10-16 2017-07-10 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of ror-gamma-t
CA2888480C (en) 2012-10-16 2021-03-16 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of ror.gamma.t
US9284308B2 (en) 2013-10-15 2016-03-15 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of RORγt
US9328095B2 (en) 2013-10-15 2016-05-03 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORgammat
EP3057422B1 (en) 2013-10-15 2019-05-15 Janssen Pharmaceutica NV Quinolinyl modulators of ror(gamma)t
US9221804B2 (en) 2013-10-15 2015-12-29 Janssen Pharmaceutica Nv Secondary alcohol quinolinyl modulators of RORγt
US10555941B2 (en) 2013-10-15 2020-02-11 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
KR20160070133A (en) 2013-10-15 2016-06-17 얀센 파마슈티카 엔.브이. Alkyl Linked Quinolinyl modulators of RORyt
US9403816B2 (en) 2013-10-15 2016-08-02 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of RORγt

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW349948B (en) * 1995-10-31 1999-01-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 2-quinolone derivatives
CA2231105C (en) * 1995-12-08 2005-09-13 Janssen Pharmaceutica N.V. Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives
TW591030B (en) * 1997-03-10 2004-06-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
ATE366250T1 (en) * 1997-04-25 2007-07-15 Janssen Pharmaceutica Nv QUINAZOLINONES INHIBIT FARNESYL TRANSFERASE
IL136462A0 (en) * 1997-12-22 2001-06-14 Schering Corp Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
AU4562799A (en) * 1998-06-15 2000-01-05 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
US6358985B1 (en) * 1998-07-02 2002-03-19 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
JP4725940B2 (en) * 1998-12-23 2011-07-13 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 1,2-Cyclic quinoline derivatives

Also Published As

Publication number Publication date
WO2001064198A2 (en) 2001-09-07
WO2001064198A3 (en) 2002-03-21
EP1267871A2 (en) 2003-01-02
CA2397256A1 (en) 2001-09-07
JP2003525238A (en) 2003-08-26

Similar Documents

Publication Publication Date Title
AU2001239275A1 (en) Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives
AU2001240658A1 (en) Farnesyl protein transferase inhibitor combinations with camptothecin compounds
AU2001246477A1 (en) Farnesyl protein transferase inhibitor combinations with platinum compounds
AU2001256166A1 (en) Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives
AU2001254672A1 (en) Farnesyl protein transferase inhibitor combinations with an her2 antibody
AU2001235496A1 (en) Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents
AU2001232799A1 (en) Protein c derivatives
AU2001244166A1 (en) Farnesyl protein transferase inhibitor combinations with further anti-cancer agents
AU2001252147A1 (en) Farnesyl protein transferase inhibitor combinations
AU2001293835A1 (en) Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives
AU2001246478A1 (en) Farnesyl protein transferase inhibitor combinations with taxane compounds
PL348294A1 (en) Farnesyl protein transferase inhibitors
AU2001247882A1 (en) Tricyclic protein kinase inhibitors
AU2001244167A1 (en) Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives
AU2001278694A1 (en) Avermectin derivatives
AU2001253197A1 (en) Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase
IL163673A0 (en) Farnesyl protein transferase inhibitors as antitumor agents
HK1054548A1 (en) Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
AU4020897A (en) 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
AU2001242434A1 (en) Farnesyl protein transferase inhibitor combinations with vinca alkaloids
PL348293A1 (en) Tricyclic farnesyl protein transferase inhibitors
AU2435199A (en) Farnesyl transferase inhibitors
AU1304801A (en) Tricyclic azaindolizine derivatives having an SPLA2- inhibiting effect
PL355887A1 (en) Farnesyl transferase inhibitors
AU3514302A (en) 0ovel farnesyl protein transferase inhibitors